Chart, Financials, Historical Prices, Industry, Insider, Messages, Options, Profile, Reports, Research, SEC Filings, more...

Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 10-Feb-2010
New Screen 

All Reports | Brokerage Reports | Independent Reports
All Reports (Showing 1 to 10 of 24)
Release
Date
 [down]
Contributor Author Title Pages Price StarMine Author Rating More Info
EPS Accuracy * Portfolio Return **
9-Feb-10New Constructs, LLCN/AAVII: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings19$10  View Abstract
9-Feb-10EconomicInvestorN/A"The Economy Matters" Report for AVII: the economy's impact on AVII's price and risk, featuring the powerful EconomicInvestor Star Rating6$15  View Abstract
8-Feb-10Plunkett Research, Ltd.Jack W. PlunkettBiotechnology & Genetics Industry Market Research and Competitive Analysis 2010569$299  View Abstract
8-Feb-10Plunkett Research, Ltd.Jack W. PlunkettBiotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary)71$199  View Abstract
5-Feb-10Ford Investor Services, Inc.N/AValue Graph: AVI BIOPHARM -- AVII1$4  View Abstract
5-Feb-10Ford Investor Services, Inc.N/AIndustry Value Graph: ASTM , AVII , NYMX , RPRX , RXII -- DRUGS3$4  View Abstract
31-Jan-10TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: AVI BIOPHARMA INC5$25  View Abstract
30-Jan-10Wright ReportsN/AWright Investors Service Comprehensive Report for AVI BioPharma, Inc.41$65  View Abstract
24-Jan-10TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: AVI BIOPHARMA INC5$25  View Abstract
20-Jan-10Zacks Investment Research Inc.N/AAVI BIOPHARM (AVII) Zacks Company Snapshot1$10  View Abstract
Next 14

Independent Reports (Showing 1 to 10 of 24)
Release
Date
 [down]
Contributor Author Title Pages Price More Info
9-Feb-10New Constructs, LLCN/AAVII: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings19$10View Abstract
9-Feb-10EconomicInvestorN/A"The Economy Matters" Report for AVII: the economy's impact on AVII's price and risk, featuring the powerful EconomicInvestor Star Rating6$15View Abstract
8-Feb-10Plunkett Research, Ltd.Jack W. PlunkettBiotechnology & Genetics Industry Market Research and Competitive Analysis 2010569$299View Abstract
8-Feb-10Plunkett Research, Ltd.Jack W. PlunkettBiotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary)71$199View Abstract
5-Feb-10Ford Investor Services, Inc.N/AValue Graph: AVI BIOPHARM -- AVII1$4View Abstract
5-Feb-10Ford Investor Services, Inc.N/AIndustry Value Graph: ASTM , AVII , NYMX , RPRX , RXII -- DRUGS3$4View Abstract
31-Jan-10TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: AVI BIOPHARMA INC5$25View Abstract
30-Jan-10Wright ReportsN/AWright Investors Service Comprehensive Report for AVI BioPharma, Inc.41$65View Abstract
24-Jan-10TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: AVI BIOPHARMA INC5$25View Abstract
20-Jan-10Zacks Investment Research Inc.N/AAVI BIOPHARM (AVII) Zacks Company Snapshot1$10View Abstract
Next 14

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.


Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.